EyePoint (EYPT) Finished Goods (2018 - 2024)

EyePoint (EYPT) reported Finished Goods of $662000.0 for Q3 2024, down 54.09% on a YoY basis from $1.4 million in Q4 2023, and down 47.67% sequentially from $1.3 million in Q2 2024.

EyePoint (EYPT) Finished Goods (2018 - 2024) Analysis & Trends

EyePoint (EYPT) has 7 years of Finished Goods data on file, last reported at $662000.0 in Q3 2024.

  • For the quarter ending Q3 2024, Finished Goods fell 54.09% year-over-year to $662000.0; the trailing twelve-month figure through Sep 2024 stood at $662000.0 (down 54.09% YoY), and the FY2023 full-year result was $1.7 million, up 332.41% from the prior year.
  • Finished Goods eased to $662000.0 in Q3 2024, from $1.3 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $2.3 million in Q1 2021 to a low of $398000.0 in Q4 2022.
  • A 5-year average of $1.3 million and a median of $1.3 million in 2020 frame the typical range for Finished Goods.
  • Across the five-year window, Finished Goods surged 509.49% in 2020 and sank 74.87% in 2021, its largest moves.
  • Tracing EYPT's Finished Goods over 5 years: stood at $1.9 million in 2020, then slumped by 74.87% to $484000.0 in 2021, then decreased by 17.77% to $398000.0 in 2022, then jumped by 332.41% to $1.7 million in 2023, then tumbled by 61.53% to $662000.0 in 2024.
  • Business Quant data shows EYPT's Finished Goods at $662000.0 in Q3 2024, $1.3 million in Q2 2024, and $1.7 million in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 EyePoint 358.61 Mn 136.07 Mn 168,000.00

Historic Data

Download Data
DateValue
Sep 30, 2024 662,000.00
Jun 30, 2024 1.27 Mn
Mar 31, 2024 1.72 Mn
Dec 31, 2023 1.72 Mn
Sep 30, 2023 1.44 Mn
Jun 30, 2023 1.70 Mn
Mar 31, 2023 1.20 Mn
Dec 31, 2022 398,000.00
Sep 30, 2022 981,000.00
Jun 30, 2022 713,000.00
Mar 31, 2022 1.04 Mn
Dec 31, 2021 484,000.00
Sep 30, 2021 1.22 Mn
Jun 30, 2021 2.09 Mn
Mar 31, 2021 2.30 Mn
Dec 31, 2020 1.93 Mn
Sep 30, 2020 1.81 Mn
Jun 30, 2020 1.34 Mn
Dec 31, 2019 316,000.00
Dec 31, 2018 40,000.00